MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 52 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $6,400 | +6300.0% | 17,777 | -91.6% | 0.00% | – |
Q1 2023 | $100 | -16.7% | 211,927 | -11.5% | 0.00% | – |
Q4 2022 | $120 | -99.6% | 239,401 | +714.0% | 0.00% | – |
Q1 2021 | $31,000 | -94.8% | 29,409 | -93.3% | 0.00% | – |
Q4 2020 | $597,000 | +1513.5% | 438,932 | +803.0% | 0.00% | – |
Q3 2020 | $37,000 | -88.0% | 48,608 | -87.8% | 0.00% | – |
Q2 2020 | $309,000 | -46.3% | 399,770 | -58.3% | 0.00% | -100.0% |
Q1 2020 | $575,000 | +168.7% | 958,507 | +916.6% | 0.00% | – |
Q4 2019 | $214,000 | -12.3% | 94,282 | -75.7% | 0.00% | – |
Q3 2019 | $244,000 | -50.1% | 388,530 | -32.0% | 0.00% | -100.0% |
Q2 2019 | $489,000 | -53.7% | 571,323 | -41.0% | 0.00% | -50.0% |
Q1 2019 | $1,056,000 | +1430.4% | 968,908 | +1195.1% | 0.00% | – |
Q3 2018 | $69,000 | -28.9% | 74,816 | -66.5% | 0.00% | – |
Q2 2018 | $97,000 | +12.8% | 223,298 | +339.9% | 0.00% | – |
Q2 2017 | $86,000 | -89.9% | 50,766 | -83.5% | 0.00% | -100.0% |
Q1 2017 | $854,000 | – | 308,154 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 1,429,532 | $1,944,000 | 0.61% |
Boxer Capital, LLC | 11,478,634 | $15,611,000 | 0.50% |
Vivo Capital, LLC | 6,451,612 | $8,774,000 | 0.39% |
Philadelphia Financial Management of San Francisco, LLC | 740,861 | $1,008,000 | 0.26% |
DCF Advisers, LLC | 305,299 | $415,000 | 0.17% |
Main Street Financial Solutions, LLC | 400,826 | $545,000 | 0.11% |
Platform Technology Partners | 158,660 | $216,000 | 0.10% |
STALEY CAPITAL ADVISERS INC | 600,000 | $816,000 | 0.05% |
MONECO Advisors, LLC | 50,000 | $81,000 | 0.04% |
CCG WEALTH MANAGEMENT, LLC | 30,000 | $41,000 | 0.04% |